Eri Nishikawa

818 total citations
20 papers, 496 citations indexed

About

Eri Nishikawa is a scholar working on Hematology, Surgery and Immunology. According to data from OpenAlex, Eri Nishikawa has authored 20 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Surgery and 5 papers in Immunology. Recurrent topics in Eri Nishikawa's work include Hematopoietic Stem Cell Transplantation (6 papers), Blood disorders and treatments (3 papers) and Transplantation: Methods and Outcomes (3 papers). Eri Nishikawa is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Blood disorders and treatments (3 papers) and Transplantation: Methods and Outcomes (3 papers). Eri Nishikawa collaborates with scholars based in Japan and United States. Eri Nishikawa's co-authors include Takashi Takahashi, Y Nimura, K Yanagisawa, Masato Nagino, Hiroyuki Osada, Toshiyuki Takeuchi, Motoshi Suzuki, Hideo Matsubara, Yoji Hayashita and Hiromichi Ebi and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Eri Nishikawa

18 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eri Nishikawa Japan 7 378 332 56 45 38 20 496
Aliaksandra Maroz Germany 5 292 0.8× 205 0.6× 24 0.4× 156 3.5× 34 0.9× 7 438
Matteo Zampini Italy 9 292 0.8× 238 0.7× 25 0.4× 104 2.3× 22 0.6× 15 390
Tianyu Xing China 11 200 0.5× 173 0.5× 65 1.2× 14 0.3× 20 0.5× 25 331
Tianxiang Hu China 13 243 0.6× 71 0.2× 35 0.6× 78 1.7× 41 1.1× 37 370
Haojie Dong China 10 220 0.6× 150 0.5× 26 0.5× 11 0.2× 23 0.6× 22 305
Tomokazu Yonezawa Japan 6 285 0.8× 261 0.8× 26 0.5× 11 0.2× 36 0.9× 11 378
Chaozeng Si China 11 182 0.5× 76 0.2× 47 0.8× 35 0.8× 46 1.2× 30 281

Countries citing papers authored by Eri Nishikawa

Since Specialization
Citations

This map shows the geographic impact of Eri Nishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Nishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Nishikawa more than expected).

Fields of papers citing papers by Eri Nishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Nishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Nishikawa. The network helps show where Eri Nishikawa may publish in the future.

Co-authorship network of co-authors of Eri Nishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Nishikawa. A scholar is included among the top collaborators of Eri Nishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Nishikawa. Eri Nishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshizaki, Tetsuya, Masato Kinoshita, Hiroshi Takayama, et al.. (2024). Improved visibility of palisade vessels within Barrett’s esophagus using red dichromatic imaging: a retrospective cross-sectional study in Japan. Clinical Endoscopy. 58(2). 269–277.
2.
Fujisawa, M., Tetsuya Yoshizaki, Eri Nishikawa, et al.. (2024). Olmesartan-associated Gastritis Observed Over Time. Internal Medicine. 64(12). 1843–1848. 1 indexed citations
3.
Hamada, Motoharu, Hideki Muramatsu, Takahisa Tainaka, et al.. (2022). Risk factors for unplanned removal of central venous catheters in hospitalized children with hematological and oncological disorders. International Journal of Hematology. 116(2). 288–294. 4 indexed citations
4.
Muramatsu, Hideki, Atsushi Narita, Daisuke Ichikawa, et al.. (2022). Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma. Cancer Medicine. 11(9). 1956–1964. 5 indexed citations
5.
Nishio, Nobuhiro, Ryo Hanajiri, Yuichi Ishikawa, et al.. (2021). A Phase I Study of CD19 Chimeric Antigen Receptor-T Cells Generated By the PiggyBac Transposon Vector for Acute Lymphoblastic Leukemia. Blood. 138(Supplement 1). 3831–3831. 9 indexed citations
6.
7.
Narita, Atsushi, Hideki Muramatsu, Daisuke Ichikawa, et al.. (2021). Relationship between plasma rabbit anti‐thymocyte globulin concentration and immunosuppressive therapy response in patients with severe aplastic anemia. European Journal Of Haematology. 107(2). 255–264. 3 indexed citations
8.
Suzuki, Takako, Jun‐ichi Kawada, Eri Nishikawa, et al.. (2020). Association between graft source and response to live-attenuated vaccination in pediatric hematopoietic stem cell transplantation recipients: a single-center retrospective study. Bone Marrow Transplantation. 55(9). 1872–1874. 1 indexed citations
9.
Hamada, Motoharu, Hideki Muramatsu, Yusuke Okuno, et al.. (2020). Diagnostic Whole Exome Sequencing for 166 Patients with Inherited Bone Marrow Failure Syndrome. Blood. 136(Supplement 1). 9–9. 1 indexed citations
10.
11.
Hama, Asahito, Hideki Muramatsu, Atsushi Narita, et al.. (2020). Risk factors for secondary poor graft function after bone marrow transplantation in children with acquired aplastic anemia. Pediatric Transplantation. 24(7). e13828–e13828. 6 indexed citations
12.
Narita, Atsushi, Hideki Muramatsu, Yinyan Xu, et al.. (2019). High Natural Killer Cell Count at Diagnosis Predicts a Good Response to Immunosuppressive Therapy in Aplastic Anemia. Blood. 134(Supplement_1). 2505–2505. 1 indexed citations
13.
Narita, Atsushi, Hideki Muramatsu, Yusuke Okuno, et al.. (2017). Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia. British Journal of Haematology. 178(6). 954–958. 13 indexed citations
14.
15.
Narita, Atsushi, Hideki Muramatsu, Yusuke Okuno, et al.. (2016). Development of Paroxysmal Nocturnal Hemoglobinuria in Children with Aplastic Anemia. Blood. 128(22). 1499–1499. 3 indexed citations
16.
Nishikawa, Eri, Hiroshi Yagasaki, Asahito Hama, et al.. (2016). Long‐term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine. Pediatric Blood & Cancer. 64(5). 7 indexed citations
17.
Hama, Asahito, Hideki Muramatsu, Atsushi Narita, et al.. (2012). Risk Factors for Donor-Type Aplasia after Bone Marrow Transplant in Children with Acquired Bone Marrow Failure. Blood. 130(21). 2461–2461. 4 indexed citations
18.
Yagasaki, Hiroshi, Maiko Kato, Maiko Hirai, et al.. (2012). Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: A single institution experience. Thrombosis Research. 130(6). e289–e293. 7 indexed citations
19.
Nishikawa, Eri, Hirotaka Osada, Yasumasa Okazaki, et al.. (2011). miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer. Cancer Research. 71(19). 6165–6173. 115 indexed citations
20.
Matsubara, Hideo, Toshiyuki Takeuchi, Eri Nishikawa, et al.. (2007). Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene. 26(41). 6099–6105. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aliaksandra Maroz Breakdown of academic impact, for papers by Matteo Zampini Breakdown of academic impact, for papers by Tianyu Xing Breakdown of academic impact, for papers by Tianxiang Hu Breakdown of academic impact, for papers by Haojie Dong Breakdown of academic impact, for papers by Tomokazu Yonezawa Breakdown of academic impact, for papers by Chaozeng Si
Rankless by CCL
2026